[Macrophage activation syndrome: a diagnostic challenge]

Area of Science:

• Immunology
• Pediatrics
• Hematology

Background:

• Macrophage activation syndrome (MAS), also known as hemophagocytic syndrome, is a rare and life-threatening condition characterized by immune dysregulation.
• It involves the overactivation of the mononuclear phagocyte system, leading to significant morbidity and mortality.
• Two primary forms exist: primary (familial) hemophagocytic lymphohistiocytosis and secondary (acquired) hemophagocytic syndrome.

Observation:

• Diagnosis of MAS presents a significant challenge for pediatricians, often being identified post-mortem.
• This study presents two pediatric cases of hemophagocytic syndrome.
• Both cases were associated with specific viral infections: parvovirus B19 and Epstein-Barr virus.

Findings:

• The findings highlight the critical association between viral infections and the development of secondary hemophagocytic syndrome.
• These cases underscore the need for heightened clinical suspicion for MAS in pediatric patients presenting with symptoms suggestive of viral illness.
• The study emphasizes the potential for parvovirus B19 and Epstein-Barr virus to trigger severe immune responses.

Implications:

• Early recognition and diagnosis of MAS are crucial for timely intervention and improved patient outcomes.
• Understanding the viral triggers of MAS can inform diagnostic strategies and potentially lead to targeted therapies.
• Further research into the pathogenesis of virus-associated MAS is warranted to develop more effective management protocols.